99 results
8-K
EX-3.4
RETA
Reata Pharmaceuticals Inc
26 Sep 23
Termination of a Material Definitive Agreement
5:25pm
for any purpose or purposes may be called by the Board of Directors, the Chairman of the Board of Directors, the President or the Secretary … . (a) Annual Meeting. As soon as practicable after each annual election of directors, the Board of Directors shall meet for the purpose of organization
8-K
EX-3.1
RETA
Reata Pharmaceuticals Inc
26 Sep 23
Termination of a Material Definitive Agreement
5:25pm
The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may now or hereafter be organized under the General … shares of stock of the Corporation that are present in person or represented by proxy at the meeting duly called for such purpose and that are entitled
8-K
EX-3.3
RETA
Reata Pharmaceuticals Inc
26 Sep 23
Termination of a Material Definitive Agreement
5:25pm
Inc.
ARTICLE THREE
The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may now or hereafter
8-K
EX-3.2
RETA
Reata Pharmaceuticals Inc
26 Sep 23
Termination of a Material Definitive Agreement
5:25pm
for any purpose or purposes may be called by the Board of Directors, such meeting to be held at such place, date and hour as shall be designated … , the Board of Directors shall meet for the purpose of organization and the transaction of other business, unless it shall have transacted all such business
DEFM14A
RETA
Reata Pharmaceuticals Inc
22 Aug 23
Proxy related to merger
8:00am
(the “special meeting”) at www.proxydocs.com/RETA, for the purpose of acting on the following matters:
To consider and vote upon a proposal to approve … Pharmaceuticals, Inc.
Biogen Inc.
River Acquisition, Inc.
THE SPECIAL MEETING
Date, Time and Place
Purpose of Special Meeting
Record Date, Stock
PREM14A
25vf3h0 10pya5mx5lz
11 Aug 23
Preliminary proxy related to merger
4:38pm
PREM14A
ih13tlucf7piaf8g
11 Aug 23
Preliminary proxy related to merger
4:38pm
DEFA14A
piiff0 143dr2ot
31 Jul 23
Additional proxy soliciting materials
7:05am
8-K
vo2zt oelcxcq3m5
31 Jul 23
Voting and Support Agreement
7:01am
8-K
EX-2.1
cp8iopvtcsoc663e
31 Jul 23
Voting and Support Agreement
7:01am
DEFA14A
k43qzsje6g47azdhz6
28 Jul 23
Additional proxy soliciting materials
5:25pm
DEFA14A
EX-99.1
quqcj8
28 Jul 23
Additional proxy soliciting materials
7:17am
8-K
EX-99.1
0cyza2vh9hlwh1f07
28 Jul 23
Biogen to Acquire Reata Pharmaceuticals
7:16am
8-K
EX-99.2
dho0so46i0ii
10 May 23
Reata Pharmaceuticals, Inc. Announces First Quarter 2023 Financial
6:45am